Abstract
Background
The impact of intragastric balloon (IGB) on obesity-related illnesses and quality of life (QOL) has not been previously investigated.
Method
One hundred and nineteen consecutive obese patients (86 females; mean age 37.8; mean body weight (BW) 103.7 ± 24.1 kg; mean BMI 38.4 ± 8.0 kg/m2) who underwent IGB were evaluated for improvement on obesity-related illnesses and QOL after weight reduction in a multidisciplinary university referral center. Bioenterics Intragastric balloon (BIB®) system was employed in the study.
Results
Mean treatment period was 169.9 ± 34.8 days. Mean BW, BMI, and excess body weight loss were 12.4 ± 6.9 kg, 4.6 ± 2.7 kg/m2, and 45.1 ± 35.3%. Mean waist circumference and biceps fold and triceps fold loss were 10.5 ± 8.3, 9.8 ± 8.5, and 8.7 ± 7.4 cm respectively. Metabolic syndrome was decreased from 42.9% to 15.1% after IGB (p < 0.0005). Improvement of obesity-related illnesses were significant in fasting glucose, cholesterol, triglyceride, C-reactive protein, and blood pressure (p < 0.005).In 28 diabetes patients, HBA1C level was significantly decreased as compared to baseline (7.4 vs. 5.8%; p < 0.0005). The QOL of patients was significantly improved after IGB (p < 0.05). No serious complication related to IGB was observed. Four patients (3.3%) had intolerence and required early removal of balloon. Thirty-one patients (26%) received further bariatric surgery after IGB.
Conclusions
IGB produces meaningful weight loss and significantly improves obesity-related illnesses and quality of life.
Similar content being viewed by others
References
Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg 2005;15:751–7.
Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982;1:198–9.
Doldi SB, Micheletto G, Perrini MN, et al. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg 2002;12:583–7.
Loffredo A, Cappuccio M, De Luca, et al. Three years experience with the new intragastric balloon, and a preoperative test for success with restrictive surgery. Obes Surg 2001;11:330–3.
Methus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon free follow-up. Gastrointest Endosc 2005;61:19–27.
Evans JD, Scott MH. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg 2001;88:1245–8.
Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of intragastric balloon. Obes Surg 2004;14:991–8.
BioEnterics Intragastric Balloon. The Italian experience with 2515 patients. Obes Surg 2005;15:1161–4.
BioEnterics Intragastric Balloon (BIB). A short-term, double-blind, randomized, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond) 2006;30:129–33.
Busetto L, Enzi G, Inelmen EM, et al. Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. Chest 2005;128:618–23.
Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis 2007;3:78–83.
Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of intragastric balloon for obesity. A meta-analysis. Obes Surg 2008;18:841–6.
Forestieri P, De Palma GD, Formato A, et al. Heliosphere bag in the treatment of severe obesity: preliminary experience. Obes Surg 2006;16:635–7.
Mion F, Gincul R, Roman S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes Surg 2007;17:996.
Mui WL, So WY, Yau PY, et al. Intragastric balloon in ethnic obese Chinese: initial experience. Obes Surg 2006;16:308–13.
Mui WL, Ng EK, Tsung BY, et al. Effective and safety of intragastric balloon for treatment of morbid obesity. Zhonghua Yi Xue Za Zhi 2007;87:388–91.
Ohta M, Kitano S, Kai S, et al. Initial Japanese experience with intragastric balloon placement. Obes Surg 2008. doi:10.1007/s11695-008-9612-x, July 1.
Coskun H, Bostanci O, Dilege E, et al. BioEnterics intragastric balloon: clinical outcomes of the first 100 patients—a Turkish experience. Obes Surg 2008;18:1154–6, Jun 3.
Melissas J, Mouzas J, Filis D, et al. The intragastric balloon-smoothing the path to bariatric surgery. Obes Surg 2006;16:897–902.
Ricci G, Bersani G, Rossi A, et al. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg 2008;18:1438–42, March 28.
Fernandes M, Atallah AN, Soares BG et al. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007;(1):CD004931, Jan 24, Review.
Mui WL, Ng EK, Tsang BY, et al. Laparoscopic sleeve gastrectomy in ethnic obese Chinese. Obes Surg 2005. doi:10.1007/s11695-008-9538-3, May 28.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mui, W.LM., Ng, E.KW., Tsung, B.YS. et al. Impact on Obesity-Related Illnesses and Quality of Life Following Intragastric Balloon. OBES SURG 20, 1128–1132 (2010). https://doi.org/10.1007/s11695-008-9766-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-008-9766-6